Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries

Completed · Early Phase 1

Conditions studied: Pain

In brief

The purpose of this study is to determine if intrathecal hydromorphone will relieve pain as well as intrathecal morphine after cesarean delivery, with fewer side effects.

Key facts

Study ID

NCT01866254

Run by

Grace Shih, MD

People needed

45

Starts

2013-05-01

Expected to finish

2018-10-22

Last updated by the study team

2019-01-03

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Scheduled for elective Cesarean sections under spinal anesthesia or combined spinal anesthesia
• ASA status of I-III
• BMI < 40
• Able to understand and sign informed consent

You may not qualify if…

• Severe pre-eclampsia
• Conversion to general anesthetic
• History of chronic opioid use
• Allergy to morphine, or hydromorphone
• Hyperemesis gravidarum
• Emergency case
• Patients who have an infection at the intended site of spinal insertion

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.